BR-14

N/A

Report date: 2026/04/07 14:22:51

Base Information

Drug NameBR-14
Drug Alias NameBR14BR-14
ClassificationDiagnostic agent (In vivo) > Contrast agent
Mechanisms of ActionUltrasonography enhancers
TargetsUpdating
Therapy Area/IndicationsCardiomyopathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Virginia
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Virginia
Active IndicationsN/A
Inactive IndicationsCardiomyopathies

Other Information

ATC CodeN/A
Related LinksN/A